Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 13  •  04:00PM ET
32.83
Dollar change
+0.38
Percentage change
1.18
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsU.S. Return% 1Y6.63% Total Holdings51 Perf Week-0.36%
SponsorThemes ETFs ETF Type Tagsequity Return% 3Y- AUM985.39K Perf Month-1.87%
Fund Family Bond Type Tagsmid-large-cap Return% 5Y- NAV/sh Perf Quarter-2.89%
IndexSolactive US R&D Champions Index Average Maturity TagsR&D Return% 10Y 52W High35.18 -6.67% Perf Half Y1.08%
Index Weighting Commodity Type Tags- Return% SI 52W Low23.68 38.66% Perf YTD-1.36%
Active/Passive Quant Type Tags- Flows% 1M0.00% Volatility0.00% 0.06% Perf Year5.92%
Dividend TTM0.14 (0.43%) ESG Type Tags- Flows% 3M0.00% ATR (14)0.33 Perf 3Y-
Dividend Ex-DateDec 18, 2025 Dividend Type Sector/Theme Flows% YTD0.00% RSI (14)44.55 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta1.27 Perf 10Y-
Expense0.29% Growth/Value SMA20-1.47% Flows% 3Y Rel Volume0.13 Prev Close32.45
Inverse/Leveraged Market Cap SMA50-2.13% Flows% 5Y Avg Volume0.05K Price32.83
IPODec 13, 2023 Option/ShortYes / No SMA2002.59% Trades Volume7 Change1.18%
Themes US R&D Champions ETF seeks to track the performance, before fees and expenses, of the Solactive US R&D Champions Index. The index is designed to provide exposure to U.S. companies in the large- and mid- capitalization segments that rank in the top 50 companies based on the index Provider's R&D intensity metric. The fund will invest, under normal circumstances, at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in securities that comprise the index. The fund is non-diversified.